The recognition follows a rigorous evaluation of thousands of firms, where Octagos was measured against financial performance, reputation, and online engagement. Central to the company's clinical standing is its proprietary Atlas AI engine, which operates alongside IBHRE-certified specialists. A study published in JACC: Advances highlighted this Two-Brain Approach, reporting 99.5% accuracy and 99.1% sensitivity during the analysis of over 690,000 device transmissions.
Octagos Retains Spot on TIME's Global HealthTech List
For the second year running, Houston-based Octagos has secured a place on TIME and Statista’s World’s Top HealthTech Companies list. As the only cardiac remote monitoring firm included in the 2026 ranking, the company earned a Very High performance rating within the competitive AI and Data Analytics category.
Currently, Octagos manages cardiac data for nearly 1,000,000 patients across more than 400 U.S. clinical locations. By integrating directly with electronic health records, the company aims to reduce administrative overhead, with clinics reporting a 65% decrease in clinical burden. Dr. Shanti Bansal, founder and CEO, noted that the objective is to embed intelligent layers into care delivery, allowing medical teams to prioritize patient interaction over manual data processing.
Comments (0)
No comments yet. Be the first!